Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Interferon-beta(1b) treatment in neuromyelitis optica.
Biomarkers for Brain Disorders: Challenges and Opportunities
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
SigmaPharm Laboratories Products
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
Visualization of myelination in GFP-transgenic zebrafish.
Information for healthcare professionals: Rituximab
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
From Bugs to Brains: the gut microbiome in neurological health
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
Chemical and Biological Therapeutic Approaches to Neurological Disorders III

Pages